Apogee Therapeutics, Inc. APGE Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 32.6×+16.8× | 26.6×+8.0× | 15.9×-0.5× | 16.4×-11.3× | 15.8×-22.3× | |
| Valuation | ||||||
| Market capitalization | $6.28B+189% | $5.16B+100% | $2.37B-28.9% | $2.54B+14.5% | $2.17B— |
Questions, answered.
- Where do Apogee Therapeutics, Inc.'s ratios come from?
- Every ratio is computed from Apogee Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.